tirzepatide weight loss results by week after 4 weeks on Semaglutide Semaglutide and Tirzepatide Weight Loss

Another 2024 study, involving more than 400,000 patients in the Netherlands, found that people with Type 2 diabetes who used semaglutide had more than double the risk of developing NAION compared to those who didnt take the drug

So- Andrew Huberman: Good to know

The new generation of appetite-suppressing drugs using GLP-1 agonists which include the brands Ozempic, Wegovy and Mounjaro have exploded in popularity in recent years due to their ability to help people lose weight

This option is particularly valuable for those who struggle with conditions that impair nutrient absorption or need rapid results

as aresult, theyre likely to incur significantly higher health care costs

Approximately 98% of parents (326 total patients) signed the consent